Consistent Export Growth: 16.19% CAGR Over 7 Years
India's exports under HSN Sub-Chapter 3002 have grown at a compound annual rate of 16.19% over 7 fiscal years, rising from ₹6,122.41 Crore in FY 2018-19 to ₹15,063.17 Crore in FY 2024-25.
HSN Sub Chapter 3002 represents Human & animal blood prepared under GST classification. This code helps businesses identify Human & animal blood prepared correctly for billing, taxation, and trade purposes. With HSN Sub Chapter 3002, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Human & animal blood prepared.
Join our guided walkthrough to see how BUSY can transform your business operations.
GST Rate for Human & animal blood prepared under HSN Code 3002. Understand current tax rates, exemptions, and legal classifications to ensure accurate billing and GST filing.
Chapter No
30HSN Code
HSN Description
Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified
New GST Rate
Old GST Rate
Following tariff HSN codes fall under Human & animal blood prepared.
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other
Tariff HSN
Description
Malaria diagnostic test kits
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
Tariff HSN
Description
Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:
Tariff HSN
Description
Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
Tariff HSN
Description
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale
Tariff HSN
Description
Other
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins
Tariff HSN
Description
Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other
Tariff HSN
Description
Cell cultures, whether or not modified: Cell therapy products
Tariff HSN
Description
Cell cultures, whether or not modified: Other
Tariff HSN
Description
Other : Human blood
Tariff HSN
Description
Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)
Tariff HSN
Description
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins
Tariff HSN
Description
Other : Other
India’s Exports
FY 2024-25₹15,063 Cr
0.4067% of India’s total exports
India’s Imports
FY 2024-25₹11,034 Cr
0.1809% of India’s total imports
Trade Balance
FY 2024-25₹4,029 Cr
Surplus rank #84 of 1233 subchapters
% of Chapter 30
FY 2024-257.24%
Share of Chapter 30’s total exports in FY 2024-25
Import side: 43.74% of Chapter 30’s imports
Rank Within Chapter 30
FY 2024-25#2 of 6
Position by export value among subchapters in Chapter 30
Import-side rank: #1 of 6
At a glance
16.19%
Export CAGR
FY 2018-19 → FY 2024-25 · 7 fiscal years
#36
National Export Rank
of 1233 subchapters by export value, FY 2024-25
+21.85%
Peak Growth Year
FY 2020-21 · strongest single-year move
7.24%
Contribution to Ch. 30
Share of Chapter 30 exports in FY 2024-25
7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
Balance
+806.16
Exports
6,122.41 ₹ Cr
0.2667% share
— YoY
5.93% of Ch. 30
Imports
5,316.25 ₹ Cr
0.1480% share
— YoY
36.46% of Ch. 30
Balance
+576.12
Exports
7,453.44 ₹ Cr
0.3375% share
+21.74% YoY
6.45% of Ch. 30
Imports
6,877.32 ₹ Cr
0.2050% share
+29.36% YoY
41.60% of Ch. 30
Balance
+550.02
Exports
9,082.04 ₹ Cr
0.4223% share
+21.85% YoY
6.32% of Ch. 30
Imports
8,532.02 ₹ Cr
0.2928% share
+24.06% YoY
45.06% of Ch. 30
Balance
+1,805.52
Exports
10,918.65 ₹ Cr
0.3479% share
+20.22% YoY
7.55% of Ch. 30
Imports
9,113.13 ₹ Cr
0.1994% share
+6.81% YoY
35.59% of Ch. 30
Balance
+3,437.54
Exports
11,792.34 ₹ Cr
0.3257% share
+8.00% YoY
7.39% of Ch. 30
Imports
8,354.80 ₹ Cr
0.1453% share
−8.32% YoY
39.74% of Ch. 30
Balance
+5,396.20
Exports
13,931.50 ₹ Cr
0.3850% share
+18.14% YoY
7.61% of Ch. 30
Imports
8,535.30 ₹ Cr
0.1520% share
+2.16% YoY
39.88% of Ch. 30
Balance
+4,028.76
Exports
15,063.17 ₹ Cr
0.4067% share
+8.12% YoY
7.24% of Ch. 30
Imports
11,034.41 ₹ Cr
0.1809% share
+29.28% YoY
43.74% of Ch. 30
CAGR · 7-Year
Exports
16.19% /yr
Imports
12.94% /yr
reference, FY 2024-25
Export
₹2,08,128.62 Cr
Import
₹25,224.54 Cr
Trade Balance
+1,82,904.08
India's exports under HSN Sub-Chapter 3002 have grown at a compound annual rate of 16.19% over 7 fiscal years, rising from ₹6,122.41 Crore in FY 2018-19 to ₹15,063.17 Crore in FY 2024-25.
In FY 2024-25, HSN Sub-Chapter 3002 ranks #36 out of 1233 subchapters by total export value. Within Chapter 30, it ranks #2 of 6. By trade surplus, it ranks #84 of 1233.
The strongest single-year export movement for HSN Sub-Chapter 3002 was recorded in FY 2020-21, when exports surged by 21.85% over the prior year.
In FY 2024-25, India's exports of ₹15,063.17 Cr exceeded imports of ₹11,034.41 Cr, resulting in a trade surplus of ₹4,028.76 Crore — ranking #84 of 1233 by surplus magnitude.
India's imports under HSN Sub-Chapter 3002 have grown at 12.94% CAGR, reaching ₹11,034.41 Crore in FY 2024-25.
Among the 6 subchapters under Chapter 30, HSN Sub-Chapter 3002 ranks #2 by export value — accounting for 7.24% of the chapter's total exports in FY 2024-25. On the import side, it holds 43.74% share (rank #1).
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
Clear answers to common queries about HSN Sub Chapter 3002 and GST compliance.
It includes Human & animal blood prepared
Prefer separate lines per item with its HSN so each component follows its own tax treatment. If it is a naturally bundled supply, identify the principal supply and tax the whole bundle accordingly.
Not always. Spares are often classified by their own description or by the function/part rule. Check if a specific sub‑heading exists for parts of the main item and describe the part on the invoice.
Repair/service is a service supply (SAC). Parts and materials used are goods and may be billed separately with HSN. Mention both lines clearly to avoid mixing service and goods values.
Some entries use MRP/weight‑based conditions for classification. Keep pack size, retail marking and brand status on records and invoice to support the chosen HSN.
If your outward supply of Human & animal blood prepared is taxable, ITC is generally available (Sections 16–17) except blocked credits (e.g., personal use, motor vehicles in most cases). For exempt supplies, proportionate reversal is required under Rule 42/43.